Data as of Dec 12
| -0.26 / -0.64%|
The 10 analysts offering 12-month price forecasts for Hospira Inc have a median target of 41.00, with a high estimate of 49.00 and a low estimate of 31.00. The median estimate represents a +1.86% increase from the last price of 40.25.
The current consensus among 13 polled investment analysts is to Hold stock in Hospira Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.